Enovix Corporation (ENVX) SEC Filings & Earnings Calls
EquiReason read 16 Enovix Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-10-22 — Company corrects unauthorized media report of ~$100M 2027 revenue; clarifies revenue growth driven by drone/defense/industrial pipeline ($216M), not smartphone; shipments to smart .
Source: SEC EDGAR filings · figures as of 2026-07-05 · read by EquiReason
- Market cap
- 612.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
22 Oct 20268-K · 7.01Company corrects unauthorized media report of ~$100M 2027 revenue; clarifies revenue growth driven by drone/defense/industrial pipeline ($216M), not smartphone; shipments to smart eyewear customer, not smartphone maker.open
Figures in the filing · each found in the filing text
| Drone, defense and industrial pipeline · consolidated · Q3-2026 | $216M | |
| Production sample cells shipped to smart eyewear customer · consolidated · Q3-2026 | 17,000 |
Risks flagged
Unauthorized media disclosure of revenue estimate creates confusion and potential misguidance risk
“The 2027 estimated revenue disclosed in the article was not a Company-authorized disclosure, and investors should not rely on those statements as Company guidance for 2027” · word for word
Revenue concentration risk: growth dependent on drone, defense and industrial pipeline conversion
“current expectation is that revenue growth will be primarily driven by its drone, defense and industrial pipeline” · word for word
13 Oct 20268-K · 2.02, 7.01Q3'26 revenue $11.0M beat guidance of $9-10M, up 38% YoY; drone/defense pipeline $216M; leadership realignment; cost reduction plan announced.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $11M | +38% y/y |
| Drone, defense and industrial pipeline · drone_defense_industrial · Q3-2026 | $216M | |
| Drone pipeline · drone · Q3-2026 | $150M | |
| Loss from operations (non-GAAP) · Q3-2026 | $29M | |
| Net loss per share (non-GAAP) · Q3-2026 | $0.14 | |
| Capital expenditures · Q3-2026 | $3M | |
| Cash and cash equivalents · Q3-2026 | $512M | |
| Production samples shipped (smart eyewear) · smart_eyewear · YTD-2026 | 17,000 | |
| Stock repurchases · Q3-2026 | $6M |
Guidance
Q3'26 revenue raised to ~$11.0M from $9.0-10.0M; Q3'26 non-GAAP operating loss improved to ~($29.2)M from ($29.0-32.0)M; Q3'26 capex lowered to ~$3.0M from $8.0-12.0M; Q4 orders already exceeded Q3 total revenue.
Revenue beat guidance; Q4 orders strong; pipeline growing; cost reduction plan initiated.
Risks flagged
Dependence on defense/drone market concentration; execution risk in scaling Korean production.
“Drone and defense customers accounted for approximately 70% of Q3'26 revenue.” · word for word
Continued operating losses; cost reduction plan yet to show results.
“Loss from operations ~($39.3)M GAAP; cost reduction plan announced but not yet implemented.”
17 Aug 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Guidance
Reaffirms Q3'26 financial guidance and reiterates technical progress on cycle life.
Risks flagged
Leadership transition risk due to CEO resignation; mitigated by interim CEO and reaffirmed guidance.
“CEO resigned to pursue other opportunity; no disagreement with company; guidance reaffirmed.”
12 Aug 20268-K · 2.02Q2 2026 revenue $9.0M, up 21% YoY, at high end of guidance; smart eyewear ramp with initial revenue; drone/defense pipeline grew 41% to $183M; lead smartphone customer passed 1,000-cycle test; cash $552.1M; Q3 guidance $9-10M revenue.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $9M | +21% y/y |
| GAAP Gross Margin · Q2-2026 | 14.4% | |
| Non-GAAP Gross Margin · Q2-2026 | 19.9% | |
| GAAP Net Loss Per Share · Q2-2026 | $-0.20 | -9% y/y |
| Non-GAAP Net Loss Per Share · Q2-2026 | $-0.13 | 0% y/y |
| Cash, Cash Equivalents, and Marketable Securities · Q2-2026 | $552M | |
| Drone, Defense, and Industrial Pipeline · Drone, Defense, and Industrial · Q2-2026 | $183M | +41% y/y |
| Smart Eyewear Batteries Shipped · Smart Eyewear · Q2-2026 | 2,100 | |
| Smart Eyewear Order Book · Smart Eyewear · Q2-2026 | 50,000 | |
| Capital Expenditures · Q2-2026 | $10M |
Guidance
Q3 2026 revenue $9.0-10.0M (vs Q3 2025 $8.0M); non-GAAP loss from ops ($29.0-32.0)M; non-GAAP EPS ($0.13-0.17); capex $8.0-12.0M
Q3 2026 revenue guidance of $9.0-10.0M implies 13-25% YoY growth, at or above Q2 2026 actual of $9.0M; capex increasing to support capacity expansion; gross margin under pressure from product mix shift.
Risks flagged
Gross margin compression due to product mix shift; profitability still distant.
“GAAP gross margin declined 11.6 pp YoY to 14.4%; non-GAAP gross margin declined 10.9 pp to 19.9%.”
Smartphone qualification still pending; final test completion expected in Q4 2026, with system-level field testing to follow.
“Final accelerated cycle-life test for smartphone qualification underway, completion expected in Q4 2026.”
Operating losses remain significant; non-GAAP loss from operations guided at $29-32M for Q3 2026.
“Non-GAAP loss from operations Q3 2026 guidance ($29.0 - 32.0) million.”
12 Aug 202610-QEnovix reported Q2 FY2026 results with 21% revenue growth driven by defense sales, but gross profit declined and cash burn remains high.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $9M | +21% y/y |
| Gross profit · Q2-2026 | $1M | -33% y/y |
| Net loss · Q2-2026 | $-43M | -3% y/y |
| Zone 1 dicing yield · Q2-2026 | 84.0% | |
| Drone/defense pipeline · Q2-2026 | $183M | |
| Cash, cash equivalents, restricted cash, and short-term and long-term investments · Q2-2026 | $552M |
Risks flagged
Continued operating losses and cash burn
“We are not profitable and have incurred losses in each year since our inception. We anticipate these losses will continue and likely increase as we continue our manufacturing scale up.” · word for word
Debt service risk
“Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the Convertible Senior Notes, depends on our future performance.” · word for word
Manufacturing scale-up risk
“Achieving the yield, throughput and cost levels necessary to support manufacturing at scale remains an important execution priority, and the timing and expected benefits of these initiatives remain subject to manufacturing and operational risks.” · word for word
9 Jul 20268-K · 5.02Base Salary $440,000.00; Target Bonus Percentage 60; RSU Grant Value $4Mopen
Figures in the filing · each found in the filing text
| Base Salary · FY2026 | $440000.00 | |
| Target Bonus Percentage · FY2026 | 60.0% | |
| RSU Grant Value · FY2026 | $4M | |
| RSU Grant Value (Vested) · FY2026 | $100000.00 |
Risks flagged
Key person dependency on new COO for manufacturing ramp; execution risk remains.
“COO appointment with significant equity incentives; prior experience in high-volume manufacturing at Apple may mitigate risk.”
14 May 202610-QRevenue $8M (+49% y/y); Net loss attributable to Enovix $-38M (+63% y/y); Gross profit $2M (+495% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $8M | +49% y/y |
| Net loss attributable to Enovix · Q1-2026 | $-38M | +63% y/y |
| Gross profit · Q1-2026 | $2M | +495% y/y |
| Cash and cash equivalents · 2026-04-05 | $89M | -53% y/y |
| Operating cash flow · Q1-2026 | $-33M | +96% y/y |
| Free cash flow · Q1-2026 | $-36M | +56% y/y |
Risks flagged
Continued operating losses
“We have incurred operating losses and negative cash flows from operations since our inception through April 5, 2026 and expect to incur operating losses for the foreseeable future.” · word for word
High debt burden
“Long-term debt, net $520,160 (thousands) as of April 5, 2026.”
Securities class action litigation
“In January 2023, purported Company stockholders filed securities class action complaints... alleging violations of Sections 10(b) and 20(a) of the Exchange Act” · word for word
13 May 20268-K · 2.02Global Pipeline for Korea Products $130M; MX-1 Drone Cell Energy Density 360; Zone 1 Dicing Yield 80earningsopen
Figures in the filing · each found in the filing text
| Global Pipeline for Korea Products · Korea · Q1-2026 | $130M | |
| MX-1 Drone Cell Energy Density · MX-1 Drone · Q1-2026 | $360.00 | |
| Zone 1 Dicing Yield · Fab2 · Q1-2026 | 80.0% |
Risks flagged
Smartphone qualification taking longer than anticipated.
“We recognize this qualification process has taken longer than we originally anticipated.” · word for word
Cycle-life testing under updated frameworks still ongoing.
“cycle-life testing under these enhanced protocols remains ongoing.” · word for word
5 May 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen
Risks flagged
Commercialization still subject to customer testing and qualification outcomes; no revenue yet.
“Forward-looking statements highlight risks in timing, qualification, and production scale-up.”
24 Apr 2026DEF 14AProxy statement filed for 2026 annual meeting, disclosing executive compensation structure and pay-for-performance alignment.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $32M | +38% y/y |
| Non-GAAP Gross Margin · FY2025 | 23.0% | |
| Cash and Marketable Securities · FY2025 | $621M | +126% y/y |
| Sales Pipeline · FY2025 | $100M | |
| Share Repurchase Executed · FY2025 | $60M | |
| CEO Realized Compensation · FY2025 | $1M | |
| CEO Target Compensation · FY2025 | $7M | |
| AIP Payout Percentage · FY2025 | 60.0% | |
| Net Loss · FY2025 | $-157M |
Risks flagged
Manufacturing Scale-Up Execution Risk
“Met some but not the threshold level of key metrics required. 0% payout for manufacturing and technology development PRSUs.” · word for word
Customer Concentration Risk
“A majority of 2025 sales were attributable to products for defense industry applications” · word for word
Pre-Commercial Stage Risk
“As a pre-commercial company, we do not have material revenue or profits against which to judge our execution” · word for word
25 Feb 202610-KNet loss attributable to Enovix $-157M; Accumulated deficit $978M; Issued U.S. patents 75open
Figures in the filing · each found in the filing text
| Net loss attributable to Enovix · FY2025 | $-157M | |
| Accumulated deficit · 2025-12-28 | $978M | |
| Issued U.S. patents · 2025-12-28 | 75 |
Risks flagged
Manufacturing Scale-Up Risk
“We rely on a new and complex manufacturing process for our operations, and achieving volume production involves a significant degree of risk and uncertainty in terms of operational performance such as yield and costs.” · word for word
Customer Concentration Risk
“One customer, a defense subcontractor in South Korea, accounted for the majority of our total revenue for the fiscal year 2025.” · word for word
Single Supplier Dependency
“We rely on a single supplier for components to manufacture products for our defense customers and any disruption in the supply of components would negatively impact our ability to perform under such contracts.” · word for word
Tariff and Trade Policy Risk
“We believe the direct impact of tariffs on our business is currently manageable given the location of our international operations; however, the indirect effects of U.S. tariffs on products containing our batteries could be significant.” · word for word
Technology Qualification Risk
“Customer qualification cycles are long and it can take many years for our products to qualify for customer shipment.” · word for word
25 Feb 20268-K · 2.02Revenue $32M (+38% y/y); Q4 revenue $11M (+16% y/y); GAAP gross profit $6Mearningsopen
Figures in the filing · each found in the filing text
| revenue · FY2025 | $32M | +38% y/y |
| Q4 revenue · Q4-2025 | $11M | +16% y/y |
| GAAP gross profit · FY2025 | $6M | |
| non-GAAP gross margin · FY2025 | 23.0% | |
| net cash used in operating activities · FY2025 | $95M | |
| free cash flow · FY2025 | $114M | |
| cash, cash equivalents and marketable securities · Q4-2025 | $621M |
Risks flagged
Smartphone qualification timeline uncertain; cycle-life testing remains key gating item.
“Cycle-life testing under high power conditions is the key gating requirement to launch our first smartphone battery” · word for word
Significant cash burn; free cash flow outflow $113.5M in FY2025.
“Free cash flow was an outflow of $28.0 million in 4Q25 and $113.5 million for full year 2025” · word for word
20 Jan 20268-K · 2.02, 5.02, 7.01Revenue Growth (Preliminary) 38earningsopen
Figures in the filing · each found in the filing text
| Revenue Growth (Preliminary) · FY2025 | 38.0% |
Risks flagged
Execution risk in manufacturing scale-up: transitioning from qualification to mass production in Malaysia.
“As Enovix enters its next phase of commercial scale, the company is realigning its operations leadership to prioritize proven, high-volume battery manufacturing expertise” · word for word
Key executive departure: COO retiring; transition risk in operations leadership.
“Ajay Marathe, the Chief Operating Officer of the Company informed the Company of his decision to retire, effective February 17, 2026.” · word for word
5 Nov 202510-QEnovix reported Q3 2025 revenue of $8.0M, up 85% YoY, driven by defense demand; gross profit turned positive; cash position strengthened.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $8M | +85% y/y |
| Gross Profit · Q3-2025 | $1M | |
| Net Loss · Q3-2025 | $-54M | +138% y/y |
| Operating Cash Flow · 9M-2025 | $-68M |
Risks flagged
Customer concentration
“Of the total revenue recognized for the fiscal quarters ended September 28, 2025 and September 29, 2024, $5.4 million and $1.4 million of revenue, respectively, resulted from sales to one South Korean defense contractor.” · word for word
Operating losses and negative cash flow
“We have incurred operating losses and negative cash flows from operations since inception through September 28, 2025 and expect to incur operating losses in the near future.” · word for word
5 Nov 20258-K · 2.02Revenue $8M (+85% y/y); Gross profit (loss) $1M; Gross Margin 18; Guidance: Q4 2025 revenue guidance raised to $9.5-10.5M from prior $7.5-8.5M; non-GAAP loss from operations guidance improved to ($30-33M) from ($31-35M).earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $8M | +85% y/y |
| Gross profit (loss) · Q3-2025 | $1M | |
| Gross Margin · Q3-2025 | 18.0% | |
| Operating expenses · Q3-2025 | $48M | -0% y/y |
| Loss from operations · Q3-2025 | $-47M | |
| Adjusted EBITDA · Q3-2025 | $-21M | |
| Net loss per share, basic · Q3-2025 | $-0.26 | |
| Cash, cash equivalents and marketable securities · Q3-2025 | $648M |
Guidance
Q4 2025 revenue guidance raised to $9.5-10.5M from prior $7.5-8.5M; non-GAAP loss from operations guidance improved to ($30-33M) from ($31-35M).
Q4 guidance raised on expected sequential revenue growth and improved operating leverage; capex increasing for Fab2 expansion.
Risks flagged
Dependence on lead smartphone customer for commercialization; design revision required additional lifecycle testing.
“Lead customer to perform additional lifecycle testing following our design revision” · word for word
Enovix Corporation — questions
- What did Enovix Corporation file recently?
- 16 SEC filings in the last 12 months. Latest: 8-K on 2026-10-22 — Company corrects unauthorized media report of ~$100M 2027 revenue; clarifies revenue growth driven by drone/defense/industrial pipeline ($216M), not smartphone; shipments to smart eyewear customer, not smartphone maker.
Every figure on this page comes from Enovix Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.